RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
International research confirms: lockdowns have negative impact on many young people Lockdowns have a negative impact on the physical and mental health of many young people. They get less exercise and experience more feelings of depression, loneliness and insecurity.
Nature Nanotechnology publishes RIVM research on plastics On Thursday 20 January, Nature Nanotechnology published the article Quantitative tracing of uptake and transport of submicrometre plastics in crop plants using lanthanide chelates as a dual-functional tracer.
RIVM study confirms: Tata Steel site is main source of PAHs and metals in the IJmond region A new study conducted by RIVM shows that the PAHs and metals present in the living environment of residents of the IJmond region predominantly originate from the Tata Steel site.
Quality of protective equipment insufficient during COVID-19 crisis The personal protective equipment (PPE) purchased at the national level during the COVID-19 crisis for use in the healthcare sector only partly met the required standards of quality.
200 thousand people tested positive in one week 201,536 positive COVID-19 tests were reported to RIVM last week. That is an increase of 77% compared to the previous week. Such high numbers of reported infections within just one week have never been seen before in the Netherlands.
Omicron causes 35% increase in positive COVID-19 tests, despite lockdown In the past week*, the number of reported positive COVID-19 tests increased by 35% compared to the week before that. The number of people tested by the GGD was about the same.
Vaccines very effective against hospital and ICU admissions, also for Delta variant COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
COVID-19 vaccination reduces transmission Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
Nearly 85% of people aged 18 and over have had at least one vaccination The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.